CMap Candidates
CMap (Connectivity Map) candidates are extracted from CLUE (CMap and LINCS Unified Environment), with detailed information, e.g., perturbagen time and dose, compound structure, targets, SMILES, mechanism of action. Two publicly available gene expression profiles of NAFLD are used to calculate individual connectivity scores and corresponding statistical significances for these candidates.
stats1
stats2
34330 records.
CMap ID | Pert ID | Compound Name | Targets | MoA | Compound Aliases | |
---|---|---|---|---|---|---|
C00904 | BRD-A36707673 | BRD-A36707673 | -- | -- | hydroxycholesterol | Details |
C00905 | BRD-A36774080 | BRD-A36774080 | -- | -- | -- | Details |
C00906 | BRD-A36884011 | BRD-A36884011 | -- | -- | -- | Details |
C00907 | BRD-A36938160 | BRD-A36938160 | -- | -- | 1,4-Dihydroxy-octahydro-quinoxaline-2,3-dione | Details |
C00908 | BRD-A37052580 | physostigmine | ACHE | Cholinesterase inhibitor; Acetylcholinesterase inhibitor | -- | Details |
C00909 | BRD-A37056613 | BRD-A37056613 | -- | -- | -- | Details |
C00910 | BRD-A37105798 | BRD-A37105798 | -- | -- | -- | Details |
C00911 | BRD-A37110558 | BRD-A37110558 | -- | -- | -- | Details |
C00912 | BRD-A37288617 | amfepramone | SLC6A2 | Adrenergic receptor agonist | -- | Details |
C00913 | BRD-A37347161 | BRL-52537 | -- | -- | -- | Details |
C00914 | BRD-A37390343 | amorolfine | -- | -- | -- | Details |
C00915 | BRD-A37432947 | ipratropium | CHRM1; CHRM2; CHRM3; CHRM4 | Acetylcholine receptor antagonist | -- | Details |
C00916 | BRD-A37441042 | tulobuterol | ADRB2 | Adrenergic receptor agonist | -- | Details |
C00917 | BRD-A37444045 | hydralazine | -- | -- | -- | Details |
C00918 | BRD-A37492983 | iocetamic-acid | -- | -- | -- | Details |
C00919 | BRD-A37501891 | BRD-A37501891 | -- | -- | -- | Details |
C00920 | BRD-A37523642 | BRD-A37523642 | -- | -- | -- | Details |
C00921 | BRD-A37541666 | naloxone | OPRD1; OPRK1; OPRM1 | Opioid receptor antagonist | -- | Details |
C00922 | BRD-A37630846 | daunorubicin | TOP2A | RNA synthesis inhibitor; Topoisomerase inhibitor | -- | Details |
C00923 | BRD-A37645929 | BRD-A37645929 | -- | -- | -- | Details |
C00924 | BRD-A37656721 | BRD-A37656721 | -- | -- | -- | Details |
C00925 | BRD-A37704979 | SB-203580 | MAPK14; MAPK11 | P38 MAPK inhibitor | -- | Details |
C00926 | BRD-A37735495 | BRD-A37735495 | -- | -- | -- | Details |
C00927 | BRD-A37776212 | ICI-204448 | OPRK1 | Opioid receptor agonist | -- | Details |
C00928 | BRD-A37780065 | triamcinolone | NR3C1 | Glucocorticoid receptor agonist | -- | Details |
C00929 | BRD-A37796306 | BRD-A37796306 | -- | -- | -- | Details |
C00930 | BRD-A37817666 | picrotoxin | GABRA1; GABRR1; GLRA2; GLRA3 | GABA receptor antagonist | -- | Details |
C00931 | BRD-A37828317 | anthothecol | -- | -- | -- | Details |
C00932 | BRD-A37837077 | cyclazosin | ADRA1B | Adrenergic receptor antagonist | -- | Details |
C00933 | BRD-A37867643 | safrolglycol | -- | -- | -- | Details |
C00934 | BRD-A37942872 | eucatropine | -- | -- | -- | Details |
C00935 | BRD-A37959677 | estrone | ESR1 | Estrogen receptor agonist | -- | Details |
C00936 | BRD-A38030642 | cyclosporin-a | PPIA; PPP3CA | Calcineurin inhibitor | -- | Details |
C00937 | BRD-A38066207 | BRD-A38066207 | -- | -- | -- | Details |
C00938 | BRD-A38076815 | glafenine | CFTR | DeltaF508-CFTR Corrector | -- | Details |
C00939 | BRD-A38161572 | atovaquone | -- | -- | -- | Details |
C00940 | BRD-A38218502 | metenkephalin | -- | -- | -- | Details |
C00941 | BRD-A38275906 | ST-019366 | -- | -- | -- | Details |
C00942 | BRD-A38305230 | dihydroergotamine-mesylate | -- | -- | -- | Details |
C00943 | BRD-A38350138 | ketoconazole | CYP19A1; AR | Sterol demethylase inhibitor | -- | Details |
C00944 | BRD-A38359809 | BRD-A38359809 | -- | -- | -- | Details |
C00945 | BRD-A38425832 | BRD-A38425832 | -- | -- | -- | Details |
C00946 | BRD-A38479395 | BRD-A38479395 | -- | -- | -- | Details |
C00947 | BRD-A38592941 | timonacic | -- | -- | -- | Details |
C00948 | BRD-A38675539 | cyclothiazide | SLC12A3; CA2 | Glutamate receptor modulator | -- | Details |
C00949 | BRD-A38706605 | BRD-A38706605 | -- | -- | dromostanolone-propionate | Details |
C00950 | BRD-A38747044 | KU-14R | -- | -- | -- | Details |
C00951 | BRD-A38749782 | fludrocortisone-acetate | NR3C2 | Glucocorticoid receptor agonist; Mineralocorticoid receptor agonist | -- | Details |
C00952 | BRD-A38793261 | BRD-A38793261 | RORC | ROR antagonist | -- | Details |
C00953 | BRD-A38878059 | BL-077 | -- | -- | -- | Details |
C00954 | BRD-A38898897 | GW-311616 | ELANE | Leukocyte elastase inhibitor | -- | Details |
C00955 | BRD-A38913120 | BH3I-1 | BCL2L1 | BCL inhibitor | -- | Details |
C00956 | BRD-A38936397 | BRD-A38936397 | -- | -- | -- | Details |
C00957 | BRD-A38994631 | BRD-A38994631 | -- | -- | -- | Details |
C00958 | BRD-A39031631 | BRD-A39031631 | -- | -- | -- | Details |
C00959 | BRD-A39052811 | mosapride | HTR4 | Serotonin receptor agonist | -- | Details |
C00960 | BRD-A39093044 | K784-3187 | -- | -- | K-784-3187 | Details |
C00961 | BRD-A39121618 | BRD-A39121618 | -- | -- | -- | Details |
C00962 | BRD-A39172021 | ampiroxicam | PTGS1; PTGS2 | Cyclooxygenase inhibitor | -- | Details |
C00963 | BRD-A39189014 | methoxamine | ADRA1D; ADRA1B; ADRA1A | Adrenergic receptor agonist | -- | Details |
C00964 | BRD-A39193201 | BRD-A39193201 | -- | -- | -- | Details |
C00965 | BRD-A39210489 | chlortetracycline | -- | -- | -- | Details |
C00966 | BRD-A39230911 | chlorphensin | -- | -- | chlorphenesin-carbamate | Details |
C00967 | BRD-A39255369 | DCPIB | SLC1A2 | Chloride channel antagonist; Glutamate inhibitor; Gap junction modulator | dcpib | Details |
C00968 | BRD-A39268308 | epibatidine | -- | -- | -- | Details |
C00969 | BRD-A39290993 | cyproterone | AR | Androgen receptor antagonist | -- | Details |
C00970 | BRD-A39390670 | rabeprazole | ATP4A | ATPase inhibitor; Gastrin inhibitor | -- | Details |
C00971 | BRD-A39407481 | BRD-A39407481 | -- | -- | -- | Details |
C00972 | BRD-A39415247 | BRD-A39415247 | -- | -- | norethisterone | Details |
C00973 | BRD-A39506880 | BRD-A39506880 | -- | -- | -- | Details |
C00974 | BRD-A39521712 | BRD-A39521712 | -- | -- | -- | Details |
C00975 | BRD-A39522003 | OMDM-2 | -- | -- | -- | Details |
C00976 | BRD-A39599596 | BRD-A39599596 | -- | -- | -- | Details |
C00977 | BRD-A39646320 | HC-toxin | -- | -- | hc-toxin | Details |
C00978 | BRD-A39660642 | BRD-A39660642 | -- | -- | -- | Details |
C00979 | BRD-A39671870 | homatropine | CHRM1 | Acetylcholine receptor antagonist | -- | Details |
C00980 | BRD-A39747742 | BRD-A39747742 | -- | -- | estradiol-valerate | Details |
C00981 | BRD-A39791822 | hydroxyprogesterone | PGR | Progesterone receptor agonist | -- | Details |
C00982 | BRD-A39900448 | BRD-A39900448 | -- | -- | -- | Details |
C00983 | BRD-A39903068 | sisomicin | -- | -- | -- | Details |
C00984 | BRD-A39935389 | teroxirone | -- | -- | -- | Details |
C00985 | BRD-A39969961 | eplerenone | NR3C2 | Cytochrome P450 inhibitor | -- | Details |
C00986 | BRD-A39986918 | BRD-A39986918 | -- | -- | -- | Details |
C00987 | BRD-A39996500 | monorden | -- | -- | -- | Details |
C00988 | BRD-A40010674 | BRD-A40010674 | -- | -- | -- | Details |
C00989 | BRD-A40022950 | BRD-A40022950 | -- | -- | -- | Details |
C00990 | BRD-A40084411 | CGP-12177 | ADRB1; ADRB2; ADRB3 | Adrenergic receptor agonist | -- | Details |
C00991 | BRD-A40163033 | BRD-A40163033 | -- | -- | -- | Details |
C00992 | BRD-A40177530 | citrinin | -- | -- | -- | Details |
C00993 | BRD-A40431293 | BRD-A40431293 | -- | -- | -- | Details |
C00994 | BRD-A40504327 | BRD-A40504327 | -- | -- | -- | Details |
C00995 | BRD-A40560522 | BRD-A40560522 | -- | -- | -- | Details |
C00996 | BRD-A40639672 | ketorolac | PTGS1; PTGS2 | Cyclooxygenase inhibitor | -- | Details |
C00997 | BRD-A40653516 | aramite | -- | -- | -- | Details |
C00998 | BRD-A40787240 | gemifloxacin | -- | -- | -- | Details |
C00999 | BRD-A40802033 | BRD-A40802033 | -- | -- | -- | Details |
C01000 | BRD-A40807648 | SIB-1508Y | -- | -- | -- | Details |
C01001 | BRD-A41020680 | minocycline | -- | -- | -- | Details |
C01002 | BRD-A41112154 | oleanolic-acid | -- | -- | -- | Details |
C01003 | BRD-A41114263 | BRD-A41114263 | -- | -- | -- | Details |